McDermott Will & Emery LLP
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
This invention provides compounds of Formula Iwherein B, G, A, E, R1, R2, R3, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
Array Biopharma, Inc.
A C A A A A A C A C A A A A A A A A A C A C A A A A C A A A A C C C A A A C A
A61P C07D A61P A61P A61K A61K A61P C07D A61P C07D A61K A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P C07D A61P A61P A61P A61P C07D A61P A61P A61P A61P C07D C07D C07D A61K A61P A61P C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Fredrik P. Julie Marie Joseph P. D. David Qian Weidong
Marmsäter Greschuk Lyssikatos Hennings Zhao Liu